ARVO 2026 - Denver, CO
CHRD is busy getting ready for the ARVO meeting in Denver, CO, where our investigators and collaborators will be presenting 18 different subjects covering gene therapy to translational research.
The list below provides information on some of the presentations:
Artur V. Cideciyan, Ph.D.Safety and Efficacy of ATSN-101 in Patients with Leber Congenital Amaurosis caused by Biallelic Variants in GUCY2D (LCA1): Durability Through 3 Years Post-treatmentWednesday, May 6th, 2026 | Location: Mile High 4E | 2:45 pm - 3:00 pm |
Tomas S. Aleman, M.D.Restoration of Cone-Mediated Vision After Gene Augmentation in Children with LCA5Thursday, May 7th, 2026 | Location: Bluebird Ballroom 1B | 12:15 pm - 12:30 pm |
Alejandro J. Roman, M.S.Use of Response Time in the Interpretation of Full-field Stimulus Test (FST)Sunday, May 3rd, 2026 | Location: Poster Hall | 1:00 pm - 2:45 pm |
Vivian Wu, M.S.Measuring Rod- and Cone-Photoreceptor–Specific Sensitivity with the Full-field Stimulus Test (FST) in Inherited Retinal DiseasesSunday, May 3rd, 2026 | Location: Poster Hall | 1:00 pm - 2:45 pm |
Erin O'Neil, M.D.Behavioral Assessment of Rod and Cone Sensitivity in Young Patients with Inherited Retinal Disease: Development of Pediatric Dark-adapted Stimulus Test (PDST)Sunday, May 3rd, 2026 | Location: Poster Hall | 1:00 pm - 2:45 pm |
Mariejel L. Weber, B.S.Natural History of Leber Congenital Amaurosis Associated with Pathogenic Variants in Lebercillin (LCA5): Cross-Sectional and Longitudinal ObservationsTuesday, May 5th, 2026 | Location: Poster Hall | 1:15 pm - 3:00 pm |
Alexander Sumaroka, Ph.D.Early Features of ABCA4-associated Stargardt Disease (ABCA4-STGD) in the Extrafoveal Perilesional RetinaTuesday, May 5th, 2026 | Location: Poster Hall | 3:30 pm - 5:15 pm |
Malgorzata Swider, Ph.D.Effect of Gene Therapy on Transient Pupillary Light Reflex (TPLR): Comparison of Rod- versus Cone-driven Sensitivity ImprovementsWednesday, May 6th, 2026 | Location: Poster Hall | 10:15 am - 12:00 pm |
Alexandra V. Garafalo, M.Eng.Modified Multi-Luminance Mobility Test (modMLMT) to Evaluate Therapeutic Benefit to Night Vision Mediated by Rod PhotoreceptorsWednesday, May 6th, 2026 | Location: Poster Hall | 2:00 pm - 3:45 pm |
Valérie L. Dufour, DVM, DECVO, DACVONonclinical efficacy and toxicity study of GMP-grade vector OPGx-RHO (scAAV2/5-RHO820-shRNA820) delivered by subretinal injection in a canine model of RHO-adRPThursday, May 7th, 2026 | Location: Poster Hall | 11:45 am - 1:30 pm |